Skip to content
CharitiesAidWelfare, Medical Health Aged Care

Every strand counts: Australians urged to sign up for World’s Greatest Shave

Leukaemia Foundation / World's Greatest Shave 2 mins read

Dear Editor,

 

The Leukaemia Foundation's much-loved national fundraising campaign, the World's Greatest Shave, is back for its 27th year encouraging people to shave, cut or colour their hair to raise critical funds for the 150,000 Australians living with blood cancer.

 

As the Leukaemia Foundation's biggest fundraising event of the year, our call for participation in the World's Greatest Shave has never been more urgent, with new data revealing blood cancer is on track to become Australia's most common and deadly cancer within a decade – unless we act now.

 

What we know is that while the incidence of blood cancer in Australia has soared by 79 per cent in the past 20 years, in that time only 12 per cent of blood cancer research funding has been directed towards early detection and prevention of the disease – proportionally well below that of other leading cancers.

 

It means that while blood cancer research to date has made significant strides towards improving treatment and care options for patients and their families, unfortunately, the critical issues of prevention and early detection of the disease remain unsolved.

 

It might surprise readers to learn that blood cancer is the second leading cause of cancer deaths in Australia. And yet, you cannot prevent blood cancer, nor can you screen for it or make lifestyle changes to reduce your risk of being diagnosed – it's Australia's silent and hidden cancer crisis.

 

With around 1 in 12 Australians projected to receive a blood cancer diagnosis in their lifetime, it is essential, now more than ever, that Australia invests more funding into blood cancer research focused on early detection and prevention, while continuing to bolster support services for patients and their loved ones.

 

Everyday Australians, like you and me, can do their part by signing up to the World's Greatest Shave to shave, cut or colour their hair to support the growing number of people living with blood cancer.

 

The Leukaemia Foundation has a bold goal of raising $12 million through the campaign and we cannot do it alone. Every strand of hair you change will help make a difference in the lives of Australians impacted by this disease and hopefully, one day, find a cure.

 

We urge the Australian community to sign up, or donate directly, to the World's Greatest Shave today by visiting worldsgreatestshave.com or calling 1800 500 088. 

 

Yours sincerely,

 

Chris Tanti

CEO, Leukaemia Foundation


About us:

About The Leukaemia Foundation:

The Leukaemia Foundation stands with Australia to help cure and conquer blood cancer – with care. Together we are attacking every blood cancer, from every direction, in every way we can. We stand beside every Australian to be their voice and their someone-to-turn-to, fighting to get them access to the best care. We also accelerate research that’s delivering rapid advancements in blood cancer diagnosis and treatments. Plus, we provide services and support that empower people living with any blood cancer to live well after diagnosis. You can learn more about the Leukaemia Foundation and blood cancer at leukaemia.org.au  


Contact details:

Please contact the Leukaemia Foundation media team at [email protected] or call 0473 154 079. 

Media

More from this category

  • Medical Health Aged Care
  • 07/12/2025
  • 01:41
Takeda Pharmaceutical Company Limited

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline NEWARK,…

  • CharitiesAidWelfare, International News
  • 06/12/2025
  • 07:51
International Confederation of the Society of Saint Vincent de Paul (SSVP)

The International Confederation of the Society of Saint Vincent de Paul presented its 2024 Annual Report in Brazil: 30 million people served and 18,000 projects throughout the world

Global action to transform lives all around the world The International Confederation of the Society of Saint Vincent de Paul presented its 2024 Annual…

  • Contains:
  • Medical Health Aged Care
  • 06/12/2025
  • 02:11
Arthur D. Little

Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation

NEW YORK–BUSINESS WIRE– Arthur D. Little (ADL) and Vega IT today announced the formation of Axceler8 Solutions, a 50/50 joint venture created to design,…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.